当前位置:首页 - 行情中心 - 多瑞医药(301075) - 财务分析 - 现金流量表

多瑞医药

(301075)

  

流通市值:45.99亿  总市值:45.99亿
流通股本:8000.00万   总股本:8000.00万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金171,654,185.42113,406,967.8853,532,591.21224,001,795.62
  收到其他与经营活动有关的现金260,085.653,821,127.39,703,643.1926,827,656.24
  经营活动现金流入小计171,914,271.07117,228,095.1863,236,234.4250,829,451.86
  购买商品、接受劳务支付的现金107,668,991.2572,754,460.4241,633,094.49120,575,540.54
  支付给职工以及为职工支付的现金48,502,565.0434,657,131.4718,375,699.8454,231,218.91
  支付的各项税费8,162,520.685,937,263.82,418,633.1617,799,120.51
  支付其他与经营活动有关的现金42,306,223.5730,514,646.1816,839,418.89125,401,446.37
  经营活动现金流出小计206,640,300.54143,863,501.8779,266,846.38318,007,326.33
  经营活动产生的现金流量净额-34,726,029.47-26,635,406.69-16,030,611.98-67,177,874.47
二、投资活动产生的现金流量:
  收回投资收到的现金1,035,592,216.8770,592,216.8498,987,600.12761,053,000
  取得投资收益收到的现金6,285,947.275,086,794.544,246,224.133,578,252.25
  处置子公司及其他营业单位收到的现金净额---60,000,000
  收到的其他与投资活动有关的现金24,434,549.8424,434,549.8411,000,600.82132,626,705.55
  投资活动现金流入小计1,066,312,713.91800,113,561.18514,234,425.07957,257,957.8
  购建固定资产、无形资产和其他长期资产支付的现金58,381,896.7540,422,725.9722,425,396.1640,915,510.62
  投资支付的现金981,000,000659,000,000391,000,000853,698,974.13
  取得子公司及其他营业单位支付的现金15,152,526.8415,152,526.84-47,993,950.26
  支付其他与投资活动有关的现金25,101,821.01103,107,145.6291,387,374.09207,000,000
  投资活动现金流出小计1,079,636,244.6817,682,398.43504,812,770.251,149,608,435.01
  投资活动产生的现金流量净额-13,323,530.69-17,568,837.259,421,654.82-192,350,477.21
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,190,5002,190,500190,50020,900,000
  其中:子公司吸收少数股东投资收到的现金--190,50020,900,000
  取得借款收到的现金117,700,00080,000,00045,000,000167,809,576
  收到其他与筹资活动有关的现金8,082,3265,000,000-1,900,000
  筹资活动现金流入小计127,972,82687,190,50045,190,500190,609,576
  偿还债务支付的现金81,400,00072,400,0002,500,000106,500,000
  分配股利、利润或偿付利息支付的现金7,051,001.954,904,902.62,194,444.1717,076,145.88
  支付其他与筹资活动有关的现金165,000165,00015,565,00026,389,328.87
  筹资活动现金流出小计88,616,001.9577,469,902.620,259,444.17149,965,474.75
  筹资活动产生的现金流量净额39,356,824.059,720,597.424,931,055.8340,644,101.25
五、现金及现金等价物净增加额-8,692,736.11-34,483,646.5418,322,098.67-218,884,250.43
  加:期初现金及现金等价物余额262,128,315.39262,128,315.39272,682,451.65329,002,572.34
  期末现金及现金等价物余额253,435,579.28227,644,668.85291,004,550.32110,118,321.91
补充资料:
  净利润--59,856,560.2--85,025,190.7
  资产减值准备-3,118,234.9-17,810,583.14
  固定资产和投资性房地产折旧-21,447,769.29-25,676,263.33
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-21,447,769.29-25,676,263.33
  无形资产摊销-926,415.18-1,274,544.77
  长期待摊费用摊销-117,360.69-240,275.55
  处置固定资产、无形资产和其他长期资产的损失-9,561.89--43,526.49
  固定资产报废损失---45,283.01
  公允价值变动损失----541,833.33
  财务费用-38,219.17-4,658,360.33
  投资损失--1,019,573.96--5,331,242.09
  递延所得税-1,195,388.99--2,328,337.04
  其中:递延所得税资产减少-1,315,568.24--1,913,400.5
    递延所得税负债增加--120,179.25--414,936.54
  存货的减少--3,374,986.07--18,949,467.36
  经营性应收项目的减少--3,165,321.66--32,381,268.2
  经营性应付项目的增加-12,775,852.43-25,169,974.3
  融资租入固定资产---12,455,038.55
  现金的期末余额-227,644,668.85-110,118,321.91
  减:现金的期初余额-110,118,321.91-329,002,572.34
  减:现金等价物的期初余额-152,009,993.48--
  现金及现金等价物的净增加额--34,483,646.54--218,884,250.43
公告日期2025-10-242025-08-272025-04-252025-04-18
审计意见(境内)标准无保留意见
TOP↑